Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Total value of everything the company owns
3Y CAGR
+1.9%/yr
vs -22.7%/yr prior
5Y CAGR
-10.2%/yr
Recent acceleration
Acceleration
+24.6pp
Accelerating
Percentile
P69
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $376.56M | +70.6% |
| 2024 | $220.67M | -8.7% |
| 2023 | $241.70M | -32.1% |
| 2022 | $356.05M | -32.7% |
| 2021 | $529.35M | -17.8% |
| 2020 | $644.14M | -16.5% |
| 2019 | $771.20M | -22.6% |
| 2018 | $996.54M | +173.6% |
| 2017 | $364.25M | +21.3% |
| 2016 | $300.22M | - |